de antidiabéticos orales: los inhibidores del co-transpor- tador de sodio y glucosa 2 (SGLT2). La dapagliflozina actúa como un inhibidor selectivo, reversible y. Aportaciones respecto a las otras familias de antidiabéticos orales. Update on the latest family of oral drugs marketed for the treatment of type 2 diabetes: DPP- 4. Discover ideas about Diabetes. Clasificación de los antidiabéticos orales. DiabetesPharmacologyNursingChemistrySurgeryWellnessHome Remedies Medicinal.

Author: Kajora Akizshura
Country: Kuwait
Language: English (Spanish)
Genre: Photos
Published (Last): 23 May 2008
Pages: 396
PDF File Size: 17.67 Mb
ePub File Size: 6.50 Mb
ISBN: 595-2-90768-526-1
Downloads: 30628
Price: Free* [*Free Regsitration Required]
Uploader: Bramuro

However, these agents must continue to be evaluated in long-term studies performed in clinical practice to ensure their effectiveness and safety profile, as well as to determine their precise role among all the currently available options in the treatment of type 2 diabetes.

Curr Opin Pharmacol, 4pp. Update on the latest family of oral drugs marketed for the treatment of type 2 diabetes: You can change the settings or obtain more information by clicking here. Efficacy and safety of inhalated insulin therapy in adults with diabetes mellitus. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone. Diabetes Care, 30 orsles, pp.

Contributions with respect to other families of oral antidiabetic agents. See more popular or the latest prezis.

Herbal Anti Diabetes: Antidiabeticos orales

Effect of Noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. Efficacy and safety of the dipeptydil peptidase-4 inhibitor alogliptin in patients with type 2 diabetes mellitus inadequately controlled by glyburide monotherapy.


Lancet,pp. Diabetes Obes Metab, 11pp. Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1. Curr Med Res Anntidiabeticos, 23pp.

Se continuar a navegar, consideramos que aceita o seu uso. JAMA,pp.

Efficacy and safety of incretin therapy in type 2 diabetes. Effects of exenatide exendin-4 on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

Creating downloadable prezi, be patient. The effect of smoking cessation and subsequent resumption on absortion of inhaled insulin. Diabetes Care, 32pp. In the studies performed to date, Prales inhibitors seem safe. Si antidiabeticow navegando, consideramos que acepta su uso. Continuing navigation will be considered as acceptance of this use. Vildagliptin, a dipeptidyl peptidase-IV inhibitor improves model-assessed beta cell function in patients with type 2 diabetes.

Diabetes Obes Metab, 9pp.

Aumento riesgo oralse vertebrales Aumento de IAM. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Glucagon like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression antudiabeticos increase cell mass in the pancreas of old glucose intolerant rats.

Efficacy and safety orals the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: Are you a health professional able to prescribe or dispense drugs?


Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function. Clin Ther, 28oraes. Diabetes, 54pp. Pharmacotherapy, 26pp. Antidiabeticos Orales — Download as Powerpoint Presentation.

Antidiabeticos orales

Ann Intern Med,pp. A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes.

Stein, Sitagliptin Study Group. Rc PPAR gamma, agonistas nucleares. A firewall is blocking access to Prezi content.


Eficacia reductora A1c simil a SU. The available evidence suggests that the efficacy, tolerability, safety, low drop-out rate and limited effects on weight, together with the low risk of hypoglycemic episodes, could place this group of drugs high on the treatment list in patients with type 2 diabetes.

N Engl J Med,pp. Check out this article to learn more or contact your system administrator. Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: Systematic review and meta-analysis.

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: Diabetes Metab Res Rev, 26pp.